BrainStorm Cell raises $10.5M in a private placement BrainStorm announced that it has entered into definitive agreements with a group of investors, including several healthcare-focused funds, in connection with a private placement of common stock and warrants to purchase common stock. Upon the closing of this financing, BrainStorm will receive gross proceeds of $10.5M, resulting from the issuance and sale of 42M shares of common stock at a price per share of 25c. Maxim Group LLC acted as sole placement agent for the financing.
BrainStorm CEO underappreciated by investors, Feuerstein says BrainStorm CEO Tony Fiorino is "one of the most honest and diligent investors in the health care sector," TheStreet's Adam Feuerstein writes after interviewing the executive. Feuerstein believes Fiorino is being underappreciated by investors. Shares of the microcap company seeking to development a treatment for amyotrophic lateral sclerosis are up 20% to $4.15 in pre-open trading. Reference Link